- Home
- RLJ vs PRAX Comparison
RLJ vs PRAX Comparison
Compare RLJ & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLJ
- PRAX
- Stock Information
- Founded
- RLJ 2011
- PRAX 2015
- Country
- RLJ United States
- PRAX United States
- Employees
- RLJ N/A
- PRAX N/A
- Industry
- RLJ Real Estate Investment Trusts
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- RLJ Real Estate
- PRAX Health Care
- Exchange
- RLJ Nasdaq
- PRAX Nasdaq
- Market Cap
- RLJ 1.1B
- PRAX 952.1M
- IPO Year
- RLJ 2011
- PRAX 2020
- Fundamental
- Price
- RLJ $7.03
- PRAX $52.00
- Analyst Decision
- RLJ Hold
- PRAX Strong Buy
- Analyst Count
- RLJ 6
- PRAX 10
- Target Price
- RLJ $9.21
- PRAX $93.30
- AVG Volume (30 Days)
- RLJ 2.2M
- PRAX 435.3K
- Earning Date
- RLJ 11-05-2025
- PRAX 11-05-2025
- Dividend Yield
- RLJ 8.50%
- PRAX N/A
- EPS Growth
- RLJ N/A
- PRAX N/A
- EPS
- RLJ 0.20
- PRAX N/A
- Revenue
- RLJ $1,367,020,000.00
- PRAX $7,765,000.00
- Revenue This Year
- RLJ N/A
- PRAX N/A
- Revenue Next Year
- RLJ $2.26
- PRAX $20.00
- P/E Ratio
- RLJ $35.44
- PRAX N/A
- Revenue Growth
- RLJ 1.40
- PRAX 338.45
- 52 Week Low
- RLJ $6.16
- PRAX $26.70
- 52 Week High
- RLJ $10.84
- PRAX $91.83
- Technical
- Relative Strength Index (RSI)
- RLJ 33.84
- PRAX 56.68
- Support Level
- RLJ $6.95
- PRAX $46.99
- Resistance Level
- RLJ $7.29
- PRAX $55.86
- Average True Range (ATR)
- RLJ 0.17
- PRAX 3.62
- MACD
- RLJ -0.06
- PRAX 0.56
- Stochastic Oscillator
- RLJ 9.88
- PRAX 74.41
About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value
RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.